The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: findings from the nd0612 clinical development program

HIGHLIGHTS

• who: Peter A. LeWitt from the Toulouse, France Sapienza University of Rome, Italy have published the paper: The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development program, in the Journal: (JOURNAL)
• what: The studies also explored augmenting the SC administration of ND0612 with oral levodopa/carbidopa, administered either alone or in combination with the COMT inhibitor entacapone.
• how: These studies were conducted in healthy volunteers and in PD patients experiencing an established pattern of motor fluctuations while on their current regimen of levodopa and an inhibitor of aromatic . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.